Cart
sales@molnova.com
Bortezomib-pinanediol
CAS No. 205393-22-2
Bortezomib-pinanediol( —— )
Catalog No. M21104 CAS No. 205393-22-2
Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 131 | In Stock |
|
| 5MG | 190 | In Stock |
|
| 10MG | 300 | In Stock |
|
| 25MG | 537 | In Stock |
|
| 50MG | 767 | In Stock |
|
| 100MG | 1053 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBortezomib-pinanediol
-
NoteResearch use only, not for human use.
-
Brief DescriptionBortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
-
DescriptionBortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetProteasome
-
RecptorProteasome
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number205393-22-2
-
Formula Weight518.462
-
Molecular FormulaC29H39BN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B1OC2CC3CC(C3(C)C)C2(C)O1
-
Chemical NameN-((S)-1-(((R)-3-methyl-1-((3aS4S6S7aR)-3a55-trimethylhexahydro-46-methanobenzo[d][132]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhaoxin Gu Xiuxiu et al. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.[J]. Acta Biomaterialia 2018.
molnova catalog
related products
-
MG-132
MG-132 (Z-Leu-leu-leu-al, Zlllal) is a potent, reversible, and cell-permeable proteasome inhibitor with IC50 of 0.1 and 1.2 μM for the inhibition of proteasome and calpain, respectively.
-
MLN9708
A potent, selective, orally bioavailable proteasome inhibitor with IC50 of 3.4 nM.
-
(1S,2S)-Bortezomib
(1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a reversible and selective inhibitor of the proteasome with a Ki of 0.6 nM for 20S proteasome.
